Repurposing Itraconazole as a Treatment for Advanced Prostate Cancer: A Noncomparative Randomized Phase II Trial in Men With Metastatic Castration-Resistant Prostate Cancer

BACKGROUND. The antifungal drug itraconazole inhibits angiogenesis and Hedgehog signaling and delays tumor growth in murine prostate cancer xenograft models. We conducted a noncomparative, randomized, phase II study evaluating the antitumor efficacy of two doses of oral itraconazole in men with meta...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Antonarakis, Emmanuel S., Heath, Elisabeth I., Smith, David C., Rathkopf, Dana, Blackford, Amanda L., Danila, Daniel C., King, Serina, Frost, Anja, Ajiboye, A. Seun, Zhao, Ming, Mendonca, Janet, Kachhap, Sushant K., Rudek, Michelle A., Carducci, Michael A.
Médium: Artigo
Jazyk:Inglês
Vydáno: AlphaMed Press 2013
Témata:
Genitourinary Cancer: Prostate
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3579600/
https://ncbi.nlm.nih.gov/pubmed/23340005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-314
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky